Cyclooxygenase 2 selective inhibitors: Panacea or flash in the pan?

Gastroenterology

Volumn 117, Issue 4, 1999, Pages 1002-1005

  Beejay, U ^a   Wolfe, M M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; ROFECOXIB; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; DRUG EFFECT; DRUG SAFETY; DYSPEPSIA; EDITORIAL; ENZYME INHIBITION; GASTRITIS; HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; STOMACH ULCER;

EID: 0032860621     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(99)70358-6     Document Type: Editorial

References (34)

1. M Wolfe D Lichtenstein G Singh Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs N Engl J Med 340 1999 1888 1899
2. P Needleman PC Isakson The discovery and function of COX-2 J Rheumatol 24 1997 6 8
3. 2 synthase (cyclooxygenase) in human monocytes J Biol Chem 265 1990 16737 16740
4. S Kargman S Charleson M Cartwright J Frank D Riendeau J Mancini J Evans G O'Neill Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts Gastroenterology 111 1996 445 454
5. JR Vane RM Botting Mediators from the endothelial cell and their participation in inflammation Int J Tissue React 16 1994 19 49
6. SM Cohn S Schloemann T Tessner K Seibert WF Stenson Crypt stem cell survival in the mouse intestinal epithelium is regulated by prostaglandins synthesized through cyclooxgenase-1 J Clin Invest 99 1997 1367 1379
7. WJ Lukiw NG Bazan Cyclooxygenase 2 RNA message abundance, stability, and hypervariability in sporadic Alzheimer neocortex J Neurosci Res 50 1997 937 945
8. RC Harris The macula densa: recent developments J Hypertens 14 1996 815 822
9. RP Robertson Dominance of cyclooxygenase-2 in the regulation of pancreatic islet prostaglandin synthesis Diabetes 47 1998 1379 1383
10. SG Morham R Langenbach CD Loftin HF Tiano N Vouloumanos JC Jennette JF Mahler KD Kluckman A Ledford CA Lee Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse Cell 83 1995 473 482
11. H Lim BC Paria SK Das JE Dinchuk R Langenbach JM Trzaskos SK Dey Multiple female reproductive failures in cyclooxygenase 2–deficient mice Cell 91 1997 197 208
12. H Mizuno C Sakamoto K Matsuda K Wada T Uchida H Noguchi T Akamatsu M Kasuga Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice Gastroenterology 112 1997 387 397
13. A Schmassmann BM Peskar C Stettler P Netzer T Stroff B Flogerzi F Halter Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats Br J Pharmacol 123 1998 795 804
14. JL Wallace A Bak W McKnight S Asfaha KA Sharkey WK MacNaughton Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: implications for gastrointestinal toxicity Gastroenterology 115 1998 101 109
15. R Langenbach SG Morham HF Tiano CD Loftin BI Ghanayem PC Chulada JF Mahler CA Lee EH Goulding KD Kluckman Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid–induced inflammation and indomethacin-induced gastric ulceration Cell 83 1995 483 492
16. BJ. Whittle Thirteenth Gaddum Memorial Lecture. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: integrity in the balance Br J Pharmacol 110 1993 3 17
17. EW Ehrich A Dallob I De Lepeleire A Van Hecken D Riendeau W Yuan A Porras J Wittreich JR Seibold P De Schepper DR Mehlisch BJ Gertz Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model Clin Pharmacol Ther 65 1999 336 347
18. K Seibert JL Masferrer Role of inducible cyclooxygenase (COX-2) in inflammation Receptor 4 1994 17 23
19. F Lanza T Simon H Quan Selective inhibition of cyclooxygenase-2 (COX-2) with MK-0966 (250 mg qd) is associated with less gastroduodenal damage than aspirin (ASA) 650 mg qid or ibuprofen (IBU) 800 mg tid (abstr) Gastroenterology 112 1997 A194
20. M Depre E Ehrich I De Lepeleire Demonstration of specific COX-2 inhibition by MK966 (Vioxx) in humans with supratherapeutic doses Rheumatol Eur 27 suppl 2 1998 196
21. L Laine S Harper T Simon R Bath J Johanson H Schwartz S Stern H Quan J Bolognese A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis Gastroenterology 117 1999 776 783
22. FE Silverstein DY Graham JR Senior HW Davies BJ Struthers RM Bittman GS Geis Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid ar thritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial Ann Intern Med 123 1995 241 249
23. BK Reuter S Asfaha A Buret KA Sharkey JL Wallace Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2 J Clin Invest 98 1996 2076 2085
24. O Morteau S Morham R Sellon J Boroviov O Smithies RB Sartor Genetic deficiency in cyclooxygenase-2 but not in cyclooxygenase-1 exacerbated DSS-induced acute colitis (abstr) Gastroenter-ology 112 1997 A1046
25. CJ Hawkey JA Karrasch L Szczepanski DG Walker A Barkun AJ Swannell ND Yeomans Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group N Engl J Med 338 1998 727 734
26. ND Yeomans Z Tulassay L Juhasz I Racz JM Howard CJ van Rensburg AJ Swannell CJ Hawkey A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiin-flammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group N Engl J Med 338 1998 719 726
27. AS Taha N Hudson CJ Hawkey AJ Swannell PN Trye J Cottrell SG Mann TJ Simon RD Sturrock RI Russell Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs N Engl J Med 334 1996 1435 1439
28. N Agrawal M Safdi L Wruble D Karvois P Greski-Rose B Huang Effectiveness of lansoprazole in the healing of NSAID-induced gastric ulcer in patients continuing to take NSAIDs (abstr) Gastroenterology 114 1998 A52 A53
29. LP Lipsky SB Abramson L Crofford RN Dubois LS Simon LB van de Putte The classification of cyclooxygenase inhibitors (editorial) J Rheumatol 25 1998 2298 2303
30. BF McAdam F Catella-Lawson IA Mardini S Kapoor JA Lawson GA FitzGerald Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2 Proc Natl Acad Sci USA 96 1999 272 277
31. RN DuBois A Radhika BS Reddy AJ Entingh Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors Gastroenterology 110 1996 1259 1262
32. CE Eberhart RJ Coffey A Radhika FM Giardiello S Ferrenbach RN DuBois Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1994 1183 1188
33. JCS Breitner The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease Annu Rev Med 47 1996 401 411
34. WF Stewart C Kawas M Corrada EJ Metter Risk of Alzheimer's disease and duration of NSAID use Neurology 48 1997 626 632